Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial
Abstract Background The role of intravenous immunoglobulins (IVIG) during sepsis is controversial, as different trials on IVIG have observed inconsistent survival benefits. We aimed to elucidate the possible association and clinical significance between circulating levels of immunoglobulins. Methods...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
SpringerOpen
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c4134941ea51475c9b2c7201d5ccf188 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c4134941ea51475c9b2c7201d5ccf188 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c4134941ea51475c9b2c7201d5ccf1882021-11-28T12:03:43ZHigher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial10.1186/s13613-021-00952-z2110-5820https://doaj.org/article/c4134941ea51475c9b2c7201d5ccf1882021-11-01T00:00:00Zhttps://doi.org/10.1186/s13613-021-00952-zhttps://doaj.org/toc/2110-5820Abstract Background The role of intravenous immunoglobulins (IVIG) during sepsis is controversial, as different trials on IVIG have observed inconsistent survival benefits. We aimed to elucidate the possible association and clinical significance between circulating levels of immunoglobulins. Methods In a subset of 956 patients with severe sepsis and septic shock of the multicentre, open-label RCT ALBIOS, venous blood samples were serially collected 1, 2, and 7 days after enrolment (or at ICU discharge, whichever came first). IgA, IgG and IgM concentrations were assayed in all patients on day 1 and in a subgroup of 150 patients on days 2 and 7. Ig concentrations were measured employing a turbidimetric assay, OSR61171 system. Results IgA on day 1 had a significant predictive value for both 28-day and 90-day mortality (28-day mortality, HR: 1.50 (95% CI 1.18–1.92); 90-day mortality, HR: 1.54 (95% CI 1.25–1.91)). IgG, but not IgM, on day 1 showed similar results for 28-day (HR 1.83 (95% CI 1.33–2.51) and 90-day mortality HR: 1.66 (95% CI 1.23–2.25)). In addition, lower levels of IgG but not of IgA and IgM, at day 1 were associated with significantly higher risk of secondary infections (533 [406–772] vs 600 [452–842] mg/dL, median [Q1–Q3], p = 0.007). Conclusions In the largest cohort study of patients with severe sepsis or septic shock, we found that high levels of IgA and IgG on the first day of diagnosis were associated with a decreased 90-day survival. No association was found between IgM levels and survival. As such, the assessment of endogenous immunoglobulins could be a useful tool to identify septic patients at high risk of mortality. Trial registration #NCT00707122, Clinicaltrial.gov, registered 30 June 2008Laura AlagnaJennifer M. T. A. MeessenGiacomo BellaniDaniela AlbieroPietro CaironiIrene PrincipaleLuigi VivonaGiacomo GrasselliFrancesca MottaNicolò M. AgnelliVieri ParriniStefano RomagnoliRoberto KeimFrancesca Di Marzo CapozziFabio S. TacconeWalter TacconeBarbara BottazziAlessandra BanderaAndrea CortegianiRoberto LatiniSpringerOpenarticleIgAIgGIgM ImmunoglobulinsMortalitySeptic shockSepsisMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENAnnals of Intensive Care, Vol 11, Iss 1, Pp 1-9 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
IgA IgG IgM Immunoglobulins Mortality Septic shock Sepsis Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 |
| spellingShingle |
IgA IgG IgM Immunoglobulins Mortality Septic shock Sepsis Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 Laura Alagna Jennifer M. T. A. Meessen Giacomo Bellani Daniela Albiero Pietro Caironi Irene Principale Luigi Vivona Giacomo Grasselli Francesca Motta Nicolò M. Agnelli Vieri Parrini Stefano Romagnoli Roberto Keim Francesca Di Marzo Capozzi Fabio S. Taccone Walter Taccone Barbara Bottazzi Alessandra Bandera Andrea Cortegiani Roberto Latini Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial |
| description |
Abstract Background The role of intravenous immunoglobulins (IVIG) during sepsis is controversial, as different trials on IVIG have observed inconsistent survival benefits. We aimed to elucidate the possible association and clinical significance between circulating levels of immunoglobulins. Methods In a subset of 956 patients with severe sepsis and septic shock of the multicentre, open-label RCT ALBIOS, venous blood samples were serially collected 1, 2, and 7 days after enrolment (or at ICU discharge, whichever came first). IgA, IgG and IgM concentrations were assayed in all patients on day 1 and in a subgroup of 150 patients on days 2 and 7. Ig concentrations were measured employing a turbidimetric assay, OSR61171 system. Results IgA on day 1 had a significant predictive value for both 28-day and 90-day mortality (28-day mortality, HR: 1.50 (95% CI 1.18–1.92); 90-day mortality, HR: 1.54 (95% CI 1.25–1.91)). IgG, but not IgM, on day 1 showed similar results for 28-day (HR 1.83 (95% CI 1.33–2.51) and 90-day mortality HR: 1.66 (95% CI 1.23–2.25)). In addition, lower levels of IgG but not of IgA and IgM, at day 1 were associated with significantly higher risk of secondary infections (533 [406–772] vs 600 [452–842] mg/dL, median [Q1–Q3], p = 0.007). Conclusions In the largest cohort study of patients with severe sepsis or septic shock, we found that high levels of IgA and IgG on the first day of diagnosis were associated with a decreased 90-day survival. No association was found between IgM levels and survival. As such, the assessment of endogenous immunoglobulins could be a useful tool to identify septic patients at high risk of mortality. Trial registration #NCT00707122, Clinicaltrial.gov, registered 30 June 2008 |
| format |
article |
| author |
Laura Alagna Jennifer M. T. A. Meessen Giacomo Bellani Daniela Albiero Pietro Caironi Irene Principale Luigi Vivona Giacomo Grasselli Francesca Motta Nicolò M. Agnelli Vieri Parrini Stefano Romagnoli Roberto Keim Francesca Di Marzo Capozzi Fabio S. Taccone Walter Taccone Barbara Bottazzi Alessandra Bandera Andrea Cortegiani Roberto Latini |
| author_facet |
Laura Alagna Jennifer M. T. A. Meessen Giacomo Bellani Daniela Albiero Pietro Caironi Irene Principale Luigi Vivona Giacomo Grasselli Francesca Motta Nicolò M. Agnelli Vieri Parrini Stefano Romagnoli Roberto Keim Francesca Di Marzo Capozzi Fabio S. Taccone Walter Taccone Barbara Bottazzi Alessandra Bandera Andrea Cortegiani Roberto Latini |
| author_sort |
Laura Alagna |
| title |
Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial |
| title_short |
Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial |
| title_full |
Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial |
| title_fullStr |
Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial |
| title_full_unstemmed |
Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial |
| title_sort |
higher levels of iga and igg at sepsis onset are associated with higher mortality: results from the albumin italian outcome sepsis (albios) trial |
| publisher |
SpringerOpen |
| publishDate |
2021 |
| url |
https://doaj.org/article/c4134941ea51475c9b2c7201d5ccf188 |
| work_keys_str_mv |
AT lauraalagna higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT jennifermtameessen higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT giacomobellani higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT danielaalbiero higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT pietrocaironi higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT ireneprincipale higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT luigivivona higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT giacomograsselli higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT francescamotta higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT nicolomagnelli higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT vieriparrini higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT stefanoromagnoli higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT robertokeim higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT francescadimarzocapozzi higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT fabiostaccone higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT waltertaccone higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT barbarabottazzi higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT alessandrabandera higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT andreacortegiani higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial AT robertolatini higherlevelsofigaandiggatsepsisonsetareassociatedwithhighermortalityresultsfromthealbuminitalianoutcomesepsisalbiostrial |
| _version_ |
1718408223651790848 |